Logo image of NMS

NUVEEN MN QLTY MUNI INC (NMS) Stock Overview

USA - NYSE:NMS - US6707341029

11.825 USD
-0.06 (-0.52%)
Last: 9/26/2025, 8:16:47 PM
Fundamental Rating

2

NMS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. NMS may be in some trouble as it scores bad on both profitability and health. NMS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

NMS had positive earnings in the past year.
NMS had a positive operating cash flow in the past year.
In multiple years NMS reported negative net income over the last 5 years.
In the past 5 years NMS always reported a positive cash flow from operatings.
NMS Yearly Net Income VS EBIT VS OCF VS FCFNMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

1.2 Ratios

The 3 year average ROIC (0.75%) for NMS is below the current ROIC(1.22%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.22%
ROE -0.37%
ROIC 1.22%
ROA(3y)-0.4%
ROA(5y)-0.24%
ROE(3y)-0.67%
ROE(5y)-0.54%
ROIC(3y)0.75%
ROIC(5y)1.17%
NMS Yearly ROA, ROE, ROICNMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5

1.3 Margins

In the last couple of years the Operating Margin of NMS has declined.
NMS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 37.78%
PM (TTM) N/A
GM 39.63%
OM growth 3Y-15.03%
OM growth 5Y-8.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.36%
GM growth 5Y-7.87%
NMS Yearly Profit, Operating, Gross MarginsNMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100

2

2. Health

2.1 Basic Checks

NMS has more shares outstanding than it did 1 year ago.
NMS has more shares outstanding than it did 5 years ago.
NMS has a worse debt/assets ratio than last year.
NMS Yearly Shares OutstandingNMS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
NMS Yearly Total Debt VS Total AssetsNMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

2.2 Solvency

NMS has an Altman-Z score of 0.81. This is a bad value and indicates that NMS is not financially healthy and even has some risk of bankruptcy.
NMS has a debt to FCF ratio of 27.47. This is a negative value and a sign of low solvency as NMS would need 27.47 years to pay back of all of its debts.
NMS has a Debt/Equity ratio of 0.72. This is a neutral value indicating NMS is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 27.47
Altman-Z 0.81
ROIC/WACCN/A
WACCN/A
NMS Yearly LT Debt VS Equity VS FCFNMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 3.05 indicates that NMS has no problem at all paying its short term obligations.
NMS has a Quick Ratio of 3.05. This indicates that NMS is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 3.05
Quick Ratio 3.05
NMS Yearly Current Assets VS Current LiabilitesNMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M

1

3. Growth

3.1 Past

The earnings per share for NMS have decreased strongly by -93.75% in the last year.
NMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.98%.
The Revenue has been decreasing by -1.34% on average over the past years.
EPS 1Y (TTM)-93.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-416.67%
Revenue 1Y (TTM)22.98%
Revenue growth 3Y6.69%
Revenue growth 5Y-1.34%
Sales Q2Q%-17.84%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NMS Yearly Revenue VS EstimatesNMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 591.25 indicates a quite expensive valuation of NMS.
When comparing the Price/Earnings ratio of NMS to the average of the S&P500 Index (27.32), we can say NMS is valued expensively.
Industry RankSector Rank
PE 591.25
Fwd PE N/A
NMS Price Earnings VS Forward Price EarningsNMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 38.27
EV/EBITDA N/A
NMS Per share dataNMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.78%, NMS is a good candidate for dividend investing.
NMS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 6.78%

5.2 History

On average, the dividend of NMS grows each year by 7.22%, which is quite nice.
NMS has been paying a dividend for at least 10 years, so it has a reliable track record.
NMS has decreased its dividend recently.
Dividend Growth(5Y)7.22%
Div Incr Years1
Div Non Decr Years1
NMS Yearly Dividends per shareNMS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of NMS are negative and hence is the payout ratio. NMS will probably not be able to sustain this dividend level.
DP-1865.38%
EPS Next 2YN/A
EPS Next 3YN/A
NMS Yearly Income VS Free CF VS DividendNMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

NUVEEN MN QLTY MUNI INC

NYSE:NMS (9/26/2025, 8:16:47 PM)

11.825

-0.06 (-0.52%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners8.44%
Inst Owner Change-13.69%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap69.65M
Analysts0
Price TargetN/A
Short Float %0.22%
Short Ratio0.84
Dividend
Industry RankSector Rank
Dividend Yield 6.78%
Yearly Dividend0.82
Dividend Growth(5Y)7.22%
DP-1865.38%
Div Incr Years1
Div Non Decr Years1
Ex-Date09-15 2025-09-15 (0.0665)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 591.25
Fwd PE N/A
P/S 14.3
P/FCF 38.27
P/OCF 38.27
P/B 0.99
P/tB 0.99
EV/EBITDA N/A
EPS(TTM)0.02
EY0.17%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.31
FCFY2.61%
OCF(TTM)0.31
OCFY2.61%
SpS0.83
BVpS11.88
TBVpS11.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.22%
ROE -0.37%
ROCE 1.54%
ROIC 1.22%
ROICexc 1.22%
ROICexgc 1.22%
OM 37.78%
PM (TTM) N/A
GM 39.63%
FCFM 37.37%
ROA(3y)-0.4%
ROA(5y)-0.24%
ROE(3y)-0.67%
ROE(5y)-0.54%
ROIC(3y)0.75%
ROIC(5y)1.17%
ROICexc(3y)0.75%
ROICexc(5y)1.18%
ROICexgc(3y)0.75%
ROICexgc(5y)1.18%
ROCE(3y)0.96%
ROCE(5y)1.48%
ROICexcg growth 3Y-6.82%
ROICexcg growth 5Y-6.93%
ROICexc growth 3Y-6.82%
ROICexc growth 5Y-6.93%
OM growth 3Y-15.03%
OM growth 5Y-8.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.36%
GM growth 5Y-7.87%
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 27.47
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.87
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.05
Quick Ratio 3.05
Altman-Z 0.81
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-416.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.98%
Revenue growth 3Y6.69%
Revenue growth 5Y-1.34%
Sales Q2Q%-17.84%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y116.47%
EBIT growth 3Y-9.35%
EBIT growth 5Y-9.55%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.53%
FCF growth 3Y-30.71%
FCF growth 5Y-13.65%
OCF growth 1Y-34.53%
OCF growth 3Y-30.71%
OCF growth 5Y-13.65%